Literature DB >> 27384134

Comparative Study of Heparin-Poloxamer Hydrogel Modified bFGF and aFGF for in Vivo Wound Healing Efficiency.

Jiang Wu1, Jingjing Zhu1, Chaochao He1, Zecong Xiao1, Jingjing Ye1, Yi Li1, Anqi Chen1, Hongyu Zhang1, Xiaokun Li1, Li Lin1, Yingzheng Zhao1, Jie Zheng2, Jian Xiao1.   

Abstract

Wound therapy remains a clinical challenge. Incorporation of growth factors (GFs) into heparin-functionalized polymer hydrogel is considered as a promising strategy to improve wound healing efficiency. However, different GFs incorporation into the same heparin-based hydrogels often lead to different wound healing effects, and the underlying GF-induced wound healing mechanisms still remain elusive. Herein, we developed a thermos-sensitive heparin-poloxamer (HP) hydrogel to load and deliver different GFs (aFGF and bFGF) for wound healing in vivo. The resulting GFs-based hydrogels with and without HP hydrogels were systematically evaluated and compared for their wound healing efficiency by extensive in vivo tests, including wound closure rate, granulation formation, re-epithelization, cell proliferation, collagen, and angiogenesis expressions. While all GFs-based dressings with and without HP hydrogels exhibited better wound healing efficacy than controls, both HP-aFGF and HP-bFGF hydrogels demonstrated their superior healing activity to improve wound closure, granulation formation, re-epithelization, and blood vessel density by up-regulation of PCNA proliferation and collagen synthesis, as compared to GF dressings alone. More importantly, HP-aFGF dressings exhibited the higher healing efficacy than HP-bFGF dressings, indicating that different a/bFGF surface properties lead to different binding and release behaviors in HP hydrogels, both of which will affect different wound healing efficiency. On the basis of experimental observations, the working mechanisms of different healing effects of HP-GFs on full skin removal wound were proposed. This work provides different views of the design and development of an effective hydrogel-based delivery system for GFs toward rapid wound healing.

Entities:  

Keywords:  control release; fibroblast growth factor; heparin; hydrogel; wound dressing; wound healing

Mesh:

Substances:

Year:  2016        PMID: 27384134     DOI: 10.1021/acsami.6b06047

Source DB:  PubMed          Journal:  ACS Appl Mater Interfaces        ISSN: 1944-8244            Impact factor:   9.229


  28 in total

1.  Thiol-Epoxy "Click" Chemistry to Engineer Cytocompatible PEG-Based Hydrogel for siRNA-Mediated Osteogenesis of hMSCs.

Authors:  Cong Truc Huynh; Fangze Liu; Yuxuan Cheng; Katherine A Coughlin; Eben Alsberg
Journal:  ACS Appl Mater Interfaces       Date:  2018-07-23       Impact factor: 9.229

2.  Identification of Angiogenic Cargoes in Human Fibroblasts-Derived Extracellular Vesicles and Induction of Wound Healing.

Authors:  Prakash Gangadaran; Eun Jung Oh; Ramya Lakshmi Rajendran; Hyun Mi Kim; Ji Min Oh; Suin Kwak; Chae Moon Hong; Kang Young Choi; Ho Yun Chung; Byeong-Cheol Ahn
Journal:  Pharmaceuticals (Basel)       Date:  2022-06-02

3.  aFGF Targeted Mediated by Novel Nanoparticles-Microbubble Complex Combined With Ultrasound-Targeted Microbubble Destruction attenuates Doxorubicin-Induced Heart Failure via Anti-Apoptosis and Promoting Cardiac Angiogenesis.

Authors:  Nan-Qian Zhou; Zhi-Xin Fang; Ning Huang; Yue Zuo; Yue Qiu; Li-Juan Guo; Ping Song; Jian Xu; Guang-Rui Wan; Xin-Qiao Tian; Ya-Ling Yin; Peng Li
Journal:  Front Pharmacol       Date:  2021-04-27       Impact factor: 5.810

4.  Temperature-sensitive heparin-modified poloxamer hydrogel with affinity to KGF facilitate the morphologic and functional recovery of the injured rat uterus.

Authors:  He-Lin Xu; Jie Xu; Si-Si Zhang; Qun-Yan Zhu; Bing-Hui Jin; De-Li ZhuGe; Bi-Xin Shen; Xue-Qing Wu; Jian Xiao; Ying-Zheng Zhao
Journal:  Drug Deliv       Date:  2017-11       Impact factor: 6.419

5.  Three-dimensional structure micelles of heparin-poloxamer improve the therapeutic effect of 17β-estradiol on endometrial regeneration for intrauterine adhesions in a rat model.

Authors:  Si-Si Zhang; Wei-Ting Xia; Jie Xu; He-Lin Xu; Cui-Tao Lu; Ying-Zheng Zhao; Xue-Qing Wu
Journal:  Int J Nanomedicine       Date:  2017-08-07

6.  KGF-2 and FGF-21 poloxamer 407 hydrogel coordinates inflammation and proliferation homeostasis to enhance wound repair of scalded skin in diabetic rats.

Authors:  Xuanxin Yang; Rongshuai Yang; Min Chen; Qingde Zhou; Yingying Zheng; Chao Lu; Jianing Bi; Wenzhe Sun; Tongzhou Huang; Lijia Li; Jianxiang Gong; Xiaokun Li; Qi Hui; Xiaojie Wang
Journal:  BMJ Open Diabetes Res Care       Date:  2020-05

7.  Reduction of cellular stress is essential for Fibroblast growth factor 1 treatment for diabetic nephropathy.

Authors:  Yanqing Wu; Yiyang Li; Ting Jiang; Yuan Yuan; Rui Li; Zeping Xu; Xingfeng Zhong; Gaili Jia; Yanlong Liu; Ling Xie; Ke Xu; Hongyu Zhang; Xiaokun Li; Jian Xiao
Journal:  J Cell Mol Med       Date:  2018-10-15       Impact factor: 5.310

8.  Enhancement of Wound Healing Efficacy by Increasing the Stability and Skin-Penetrating Property of bFGF Using 30Kc19α-Based Fusion Protein.

Authors:  Haein Lee; Young-Hyeon An; Tae Keun Kim; Jina Ryu; G Kate Park; Mihn Jeong Park; Junghyeon Ko; Hyunbum Kim; Hak Soo Choi; Nathaniel S Hwang; Tai Hyun Park
Journal:  Adv Biol (Weinh)       Date:  2021-01-04

9.  miR-5591-5p regulates the effect of ADSCs in repairing diabetic wound via targeting AGEs/AGER/JNK signaling axis.

Authors:  Qiang Li; Sizhan Xia; Yating Yin; Yanping Guo; Feifei Chen; Peisheng Jin
Journal:  Cell Death Dis       Date:  2018-05-01       Impact factor: 8.469

10.  A new nanoscale transdermal drug delivery system: oil body-linked oleosin-hEGF improves skin regeneration to accelerate wound healing.

Authors:  Weidong Qiang; Tingting Zhou; Xinxin Lan; Xiaomei Zhang; Yongxin Guo; Muhammad Noman; Linna Du; Jie Zheng; Wenqing Li; Haoyang Li; Yubin Lu; Hongyu Wang; Lili Guan; Linbo Zhang; Xiaokun Li; Jing Yang; Haiyan Li
Journal:  J Nanobiotechnology       Date:  2018-08-30       Impact factor: 10.435

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.